BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20190310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20191103T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20191001T130000 DTEND;TZID=America/New_York:20191001T140000 DTSTAMP:20240329T024435 CREATED:20190913T171657Z LAST-MODIFIED:20190916T123508Z UID:2945-1569934800-1569938400@bioct.org SUMMARY:Life Sciences Securities Class Action Update: Legal and Risk Best Practices for Life Sciences Companies - Webinar Presented by Aon DESCRIPTION:We believe that analyzing legal precedents by reference to the stage of drug or device development at which the setback occurs may yield useful insights and assist in risk mitigation and insurance strategies.  \n\n\n\n\n\n\n\n\n\n\n\n In this webinar we will discuss: \n\nOverview and analysis of trends in decisions involving life sciences companies with products at two distinct stages of development—pre- and post-FDA approval and takeaways that can help guide disclosure approaches\n\n\nRecent cases and what those reveal about the events that can draw a lawsuit\n\nInsight into the D&O Insurance underwriters’ reaction to the volatile life science shareholder litigation landscape\n\nSPEAKERS \nSara Brody\, Partner\, Sidley \nKristin Kraeger\, Managing Director\,\nFinancial Services Group\, Aon URL:https://bioct.org/event/legal-and-risk-best-practices-for-life-sciences-companies-webinar-presented-by-aon/ END:VEVENT END:VCALENDAR